Director Share Purchases
Updated : 07:05
LEI: 213800FLQUB9J289RU66
8 October 2019
BATM Advanced Communications Limited
("BATM" or "the Company")
Director Share Purchases
BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that, on 7 October 2019, Dr. Gideon Chitayat, Chairman of the Company, and Dr. Zvi Marom, Chief Executive Officer of the Company, purchased ordinary shares of 0.01 NIS each in the Company ("Ordinary Shares"). Dr. Chitayat purchased 159,000 Ordinary Shares and Dr. Marom purchased 100,000 Ordinary Shares, both at a price of 38.3 pence per Ordinary Share.
Following these purchases, Dr. Chitayat has an interest in 3,159,000 Ordinary Shares and Dr. Marom has an interest in 96,794,500 Ordinary Shares, representing approximately 0.7% and 22.0% respectively of the Company's issued share capital.
Enquiries:
BATM Advanced Communications | |
Dr Zvi Marom, Chief Executive Officer | +972 9866 2525 |
Moti Nagar, Chief Financial Officer | |
Shore Capital | |
Mark Percy, Anita Ghanekar, James Thomas | +44 20 7408 4050 |
Luther Pendragon | |
Harry Chathli, Claire Norbury, Joe Quinlan | +44 20 7618 9100 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Gideon Chitayat
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chairman and Director | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| BATM Advanced Communications Ltd. | |||
b)
| LEI
|
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 0.01 NIS each in BATM Advanced Communications Ltd. | |||
Identification code | IL0010849045 | ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
38.3 pence | 159,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 159,000 | ||||
- Price | 38.3 pence | ||||
e)
| Date of the transaction
| 7 October 2019 | |||
f)
| Place of the transaction
| London Stock Exchange, Main Market
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Zvi Marom
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chief Executive Officer and Director | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| BATM Advanced Communications Ltd. | |||
b)
| LEI
|
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 0.01 NIS each in BATM Advanced Communications Ltd. | |||
Identification code | IL0010849045 | ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
38.3 pence | 100,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 100,000 | ||||
- Price | 38.3 pence | ||||
e)
| Date of the transaction
| 7 October 2019 | |||
f)
| Place of the transaction
| London Stock Exchange, Main Market
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.